@correlationnet.bsky.social📢 A new article introducing the European Toolkit for the Elimination of Viral #Hepatitis in Prisons (EuroHePP) is published with a contribution of our Head of Research, Rafaela Rigoni.
Read the article here:
🔗 buff.ly/0KgUiFB
Explore the EuroHePP toolkit here:
🔗 buff.ly/iicBSzX
@aasldnews.bsky.social🔥 HOT TOPIC: A new path toward a functional cure for chronic #hepatitis B is taking shape.
This randomized trial explores combining nucleos(t)ide withdrawal with pegylated interferon to help inform future treatment strategies.
Read the article in #HEPATOLOGY: https://bit.ly/3VLgxgH
@jhumimmunity.orgHigh prevalence of #autoantibodies neutralizing type I IFNs in Japanese patients with #hepatitis C. New study from Maki Taniguchi, Satoshi Okada and colleagues (Hiroshima University):
rupress.org/jhi/article/...
@infect-net.bsky.socialThe next talk is by Stephanie Jung from @unibonn.bsky.social who talks about MDA5-dependent IFN response during Hepatitis D virus infection
#Infect-Net #Hepatitis #innateimmunity
@pippa-matt.bsky.socialConference on #LiverDisease in #Africa ( #COLDA) meeting in #AddisAbaba, #Ethiopia. Inspiring enthusiasm from researchers & clinicians to drive advances for #elimination of viral #hepatitis and liver disease in Africa. @sdgactioncampaign.org @whowpro.bsky.social @crick.ac.uk #AfricaCDC #HBV #IDSky 🧪
@viromarkers.bsky.social🧬 #IHI features #VIROMARKERS! Discover Prof. Valentina Svicher’s #research on chronic #hepatitis D
Read more 📰 www.ihi.europa.eu/news-events/...
📧 viromarkers.eu #HorizonEurope #HealthcareInnovation #MedicalResearch #ResearchAndInnovation #HIV #HDV #CMV @ihieurope.bsky.social @eatgroup.bsky.social
@ferl67.bsky.socialImmunization clinic to be hosted after hepatitis A case detected at Winnipeg school
https://www.cbc.ca/news/canada/manitoba/hepatitis-a-case-winnipeg-school-division-9.7351062
@pippa-matt.bsky.social#COLDA declaration: "Africa doesn't lack #vaccines, #diagnostics, #medicine, guidelines or expertise to tackle #hepatitis & #liver disease. The gap is #implementation. Call to #CDC to turn the #HBV tookit into a roadmap, service packages & national support." 🧪 @who.int @worldhepalliance.bsky.social
@immunizecanada.bsky.social#ThrowbackThursday We vaccinated because hepatitis B. Time tested. Life saving. #GetImmunized | www.immunize.ca/sites/defau... #hepatitis #VaccinesWork #VaccinesSaveLives
@immunizecanada.bsky.social#ThrowbackThursday We vaccinated because hepatitis A. Time tested. Life saving. #GetImmunized | www.immunize.ca/sites/defau... #hepatitis #VaccinesWork #VaccinesSaveLives
@demetrioymedio.bsky.socialLos Seguros de Sanidad Privada más de 60 enfermedades que no cubren, ni graves ni raras ni #vih ni #cancer #hepatitis etc..🤬🤬😡😖😰😤😢 #sanidadpublica #saludpublica #comunidaddemadrid #comunidadvAlenciana #aragon #canarias #baleares #murcia #galicia #ceuta #melilla #andalucia #castillayleon #extremadura
@pippa-matt.bsky.socialReflecting on 5 years of progress, with data from multiple countries across #Africa being meticulously collated to represent people living with #HBV to understand and improve clinical management, outcomes, policy and funding.
#HEPSANET
#COLDA #hepatitis
www.hepsanet.org
🧪
@pippa-matt.bsky.social“Let’s protect the next generation”
5 priorities for tackling viral #hepatitis as an epidemic in #Africa.
Prevention 💉
Diagnosis 🩸
Funding 💰
Systems ⚙️
Partnerships 🤝
(all underpinned by advocacy 💪)
@africanunion.bsky.social @who.int #COLDA
🧪
@pippa-matt.bsky.social"No-one can be treated for a condition they do not know they have..."
It's essential to scale up #hepatitis #diagnosis alongside #prevention if we are going to reach #elimination targets set for 2030.
@sdgactioncampaign.org 🧪
@pippa-matt.bsky.social#Hepatitis emergency 🔉
@africanunion.bsky.social @who.int
65m. people living w #HBV & 8m. w #HCV in #Africa; 2-3% treated. 20 member states not providing birth dose HBV #vaccine. 18 states have a national #hepatitis plan – but only 3 have funded it. Viral hep deaths ⬆️ 31% since 2000. #COLDA 🧪
@pippa-matt.bsky.socialConference on #Liver Disease in #Africa is opening in Addis Ababa, #Ethiopia this morning. Liver #cancer & #metabolic liver disease being headlined as #PublicHealth & economic threats to the continent, overlapping with endemic viral #hepatitis B.
#COLDA #diabetes #MASLD #HBV #MedSky #LiverSky 🇪🇹🧪
@jhumimmunity.orgTaniguchi et al. find the prevalence of #autoantibodies neutralizing type I IFNs is significantly higher in Japanese patients w/ #hepatitis C (2.7%) than in age-matched healthy controls (0.7%), and is even higher in those treated w/ IFN-α than in untreated individuals. rupress.org/jhi/article/...
@yemaya75.bsky.social